EPS Creative Health Technology Group Ltd.
Top
About Us
Company Profile
CEO’s Message
EPS Group
Corporate Structure
Directors and Management
Our Services
Apparel ODM Business
Pharmaceutical Development Business
HCP Business
Drug Discovery and Development
Media Center
Investor Relations
Announcement and Notices
Interim and Annual Reports
Circular
Prospectus
IR Contact
Recruit
Contact Us
ENG
繁中
简中
日本語
Media Center
2023's News
Select Year
2023's News
2022's News
2023/11/15
EPS Innovative Medicine
Patients with allergic rhinitis and allergic to cedar pollinosis have lower saliva-secretory IgA than healthy subjects
2023/09/29
EPD
Concluded a joint research agreement with C-HAS+ Co., Ltd. for exploring useful substances for anti-obesity contained in natural products
2023/09/25
EPS Innovative Medicine
Having prospect for the development of simple, highly effective and safe sublingual vaccines
2023/06/16
EPD
Joint R&D Agreement for Regenerative Medicine Using Brown Adipocytes(for Slimming/weight loss)Concluded with Medical Corporation Tomoshibikai FIRE CLINIC
2023/06/06
Group Announcement
Notice of organization chart update (Addition of New Subsidiaries to “EPS Healthcare Ltd.”)
2023/02/21
FEF Pharmaceutical
FEF Pharmaceutical Co., Ltd. and Kyoto University have initiated a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD)
ENG
繁中
简中
日本語
Top
About Us
Company Profile
CEO’s Message
EPS Group
Corporate Structure
Directors and Management
Our Services
Apparel ODM Business
Pharmaceutical Development Business
HCP Business
Drug Discovery and Development
Media Center
Investor Relations
Announcement and Notices
Interim and Annual Reports
Circular
Prospectus
IR Contact
Recruit
Contact Us
